News

Stay up to date on our latest stories.

Filters

Inspiring women of Hikma - Meet Stephanie Haas, Senior Director, Head of Hikma Rx Procurement

Story, Leadership
Inspiring women of Hikma - Meet Stephanie Haas, Senior Director, Head of Hikma Rx Procurement

Hikma launches Triamcinolone Acetonide Injectable Suspension, USP, in the US

Press Release, Product
Hikma launches Triamcinolone Acetonide Injectable Suspension, USP, in the US

Fitch upgrades Hikma Pharmaceuticals PLC’s long-term issuer default rating to ‘BBB’, outlook stable

Press Release, Corporate
Fitch upgrades Hikma Pharmaceuticals PLC’s long-term issuer default rating to ‘BBB’, outlook stable

Bio-Thera Solutions and Hikma Pharmaceuticals announce FDA approval of STARJEMZA® (ustekinumab-hmny) Injection, a biosim...

Press Release, Product
Bio-Thera Solutions and Hikma Pharmaceuticals announce FDA approval of STARJEMZA® (ustekinumab-hmny) Injection, a biosim...

Hikma announces strong medium-term Group guidance ahead of its US site visit

Press Release, Corporate
Hikma announces strong medium-term Group guidance ahead of its US site visit

Hikma announces settlement agreement for Xyrem® (sodium oxybate) U.S. class action lawsuits

Press Release, Corporate
Hikma announces settlement agreement for Xyrem® (sodium oxybate) U.S. class action lawsuits

S&P upgrades Hikma Pharmaceuticals PLC and its Senior Notes to ‘BBB’ on continued good business momentum; outlook stable

Press Release, Corporate
S&P upgrades Hikma Pharmaceuticals PLC and its Senior Notes to ‘BBB’ on continued good business momentum; outlook stable

Hikma reiterates full year guidance following good start to the year

Press Release, Corporate
Hikma reiterates full year guidance following good start to the year

Inspiring women of Hikma - Meet Nesrine Nouhi, General Manager of Hikma France

Insight, Life at Hikma
Inspiring women of Hikma - Meet Nesrine Nouhi, General Manager of Hikma France

Hikma acquires Novugen’s FDA-approved ANDA for trametinib

Press Release, Product
Hikma acquires Novugen’s FDA-approved ANDA for trametinib

Hikma signs exclusive licensing agreement with pharma& to bring innovative oncology treatment to MENA

Press Release, Business Development
Hikma signs exclusive licensing agreement with pharma& to bring innovative oncology treatment to MENA

Hikma launches Cisatracurium Besylate Injection, USP in the US

Press Release, Product
Hikma launches Cisatracurium Besylate Injection, USP in the US

Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg

Press Release, Product
Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg

Developing our pipeline in growing therapeutic areas

Story, Corporate
Developing our pipeline in growing therapeutic areas

Focusing on our quality manufacturing

Story, Corporate
Focusing on our quality manufacturing